SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-005245
Filing Date
2008-08-01
Accepted
2008-08-01 17:01:16
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b71176ipe10vq.htm 10-Q 357148
2 EX-3.1 RESTATED CERTIFICATION OF INCORPORATION OF IDERA PHARMACEUTICALS, INC., A b71176ipexv3w1.txt EX-3.1 238310
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b71176ipexv31w1.htm EX-31.1 6227
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b71176ipexv31w2.htm EX-31.2 6304
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b71176ipexv32w1.htm EX-32.1 2968
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b71176ipexv32w2.htm EX-32.2 2984
  Complete submission text file 0000950135-08-005245.txt   615433
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 08985773
SIC: 2836 Biological Products, (No Diagnostic Substances)